Maintenance Notice (5:30 AM - 12:00 PM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 192725-17-0 | Product Number: L0377
Lopinavir
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- (S)-N-[(2S,4S,5S)-5-[2-(2,6-Dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 250MG |
£44.00
|
2 | 5 |
|
| 1G |
£152.00
|
2 | 14 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | L0377 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__3__7H__4__8N__4O__5 = 628.81 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| Packaging and Container | 1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 192725-17-0 |
| Reaxys Registry Number | 9309881 |
| PubChem Substance ID | 468592179 |
| MDL Number | MFCD22628840 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 103.0 to 107.0 °C |
| Specific rotation | -22.0.0 to -26.0.0 deg(C=0.4, mathanol |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 105 °C |
| Solubility in water | Insoluble |
| Solubility (soluble in) | Ethanol, Methanol |
GHS
Related Laws:
| RTECS# | UV6264135 |
Transport Information:
| HS Number | 2933599590 |
Application
Lopinavir: A HIV-1 Protease Inhibitor
Lopinavir (ABT-378), a HIV-1 protease inhibitor, prevents cleavage of the Gag-Pol polyprotein, resulting in the production of immature, non-infectious viral particles.1,2) In clinical, lopinavir is co-formulated with ritonavir [R0116] to enhance the bioavailability and pharmacokinetics of lopinavir.3) Ritonavir inhibits the CYP3A-mediated metabolism of lopinavir, thereby providing increased plasma levels of lopinavir. In the 2020s, it has been reported that lopinavir is an effective agent that inhibits the protease activity of corona viruses, such as SARS-CoV2 and MERS.4,5) (The product is for research purpose only.)
References
- 1) ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
- 2) Human Serum Attenuates the Activity of Protease Inhibitors toward Wild-Type and Mutant Human Immunodeficiency Virus
- 3) Lopinavir-ritonavir: A new protease inhibitor (a review)
- 4) Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
- 5) A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.